Press release
Erythropoietin Drugs Market 2023 Update - Projected Revenue Surges to USD 14.41 Billion by 2028, Boasting a 5.7% Compound Annual Growth Rate (CAGR)
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/59
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก: The growth of the market is driven by factors such as the increasing prevalence of chronic kidney diseases, the rise in the number of cancer patients undergoing chemotherapy, and the growing geriatric population.
๐๐ฒ๐ฉ๐๐ฌ ๐จ๐ ๐๐ซ๐ฒ๐ญ๐ก๐ซ๐จ๐ฉ๐จ๐ข๐๐ญ๐ข๐ง ๐๐ซ๐ฎ๐ ๐ฌ: The two major types of erythropoietin drugs are biosimilars and biologics. Biosimilars are expected to dominate the market due to their cost-effectiveness compared to biologics.
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ซ๐๐๐ฌ: Erythropoietin drugs are primarily used in the treatment of anemia caused by chronic kidney disease, cancer, and other diseases. They are also used to reduce the need for blood transfusions during surgeries.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ: North America held the largest share of the market in 2020, followed by Europe and Asia Pacific. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
On the basis product type, epoetin-alfa segment is anticipated to grow with the highest revenue throughout the forecast period, owing to increase in sales of Epogen, which is the top selling brand of erythropoietin, developed by Amgen. Epogen indicated notable growth in the U.S. market as Amgen procured patent protection for this product.
By application, the kidney disorders (ESRD and Dialysis) segment accounted for a major share in 2020, and is expected to exhibit a prominent growth rate during the forecast period, owing to increase in cases of patients with kidney disease. Furthermore, ESRD is majorly responsible for prescription of EPO treatment among renal disease patients.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง -
https://www.alliedmarketresearch.com/request-for-customization/59
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
AMGEN INC.
JOHNSON AND JOHNSON
ROCHE DIAGNOSTICS
HOSPIRA INC.
LG LIFE SCIENCES LTD.
BIOCON
INTAS PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES LTD.
RANBAXY LABORATORIES LTD.
CELLTRION, INC
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/checkout-final/fbeb76f67944772a3785fb1c960404e6
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Browse more latest healthcare reports:
๐๐จ๐ฉ๐ข๐๐๐ฅ ๐๐ฑ๐ฒ๐ ๐๐ง ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/topical-oxygen-therapy-market-A16966
๐๐๐ฆ๐จ๐ฌ๐ญ๐๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/hemostats-market-A16840
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐จ๐ง ๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/companion-animal-diagnostics-market-A11127
๐๐๐๐ข๐จ๐ฌ๐ฎ๐ซ๐ ๐๐ซ๐ฒ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/radiosurgery-systems-market-A14841
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
About Us -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Drugs Market 2023 Update - Projected Revenue Surges to USD 14.41 Billion by 2028, Boasting a 5.7% Compound Annual Growth Rate (CAGR) here
News-ID: 3334610 • Views: โฆ
More Releases from allied market research
Artificial Intelligence Chip Market Share to Reach $460.9 Billion by 2034
The global artificial intelligence chip market witnessed remarkable growth in 2024, driven by rapid advancements in AI applications across industries such as automotive, healthcare, finance, and manufacturing. With rising demand for high-performance, energy-efficient chips to power edge and cloud AI workloads, major players are investing in next-gen technologies like SoC, chiplets, and 3nm fabrication. As AI adoption accelerates globally, the market is poised for sustained expansion, with Asia-Pacific emerging asโฆ
GaN Power Device Market Size to Reach $12,849.3 Million by 2033
The GaN power device market is propelled by rise in demand for energy-efficient solutions in various applications, including electric vehicles and renewable energy systems. However, high manufacturing costs and technical complexities pose challenges for the widespread adoption of GaN power devices. Advancements in technology, leading to lower production costs and improved performance offer opportunities for market growth. In addition, growing investment in green technologies and electric mobility drives the growthโฆ
Gallium-Oxide Power Devices Market Expected to Reach $86.9 Million by 2033
The gallium oxide power device market share is expected to witness considerable growth in coming years, owing to the owing to the material's superior properties, such as higher breakdown voltage and improved thermal performance compared to traditional semiconductors like silicon and even newer materials like silicon carbide (SiC) and gallium nitride (GaN). These advantages make Ga2O3 ideal for high-power applications in electric vehicles (EVs), renewable energy systems, and industrial equipment.โฆ
Homeland Security Market Share to Reach $18439.8 Billion by 2033
By type, the border security segment dominated the global market in 2023, in terms of revenue, and is expected to lead the market throughout the forecast period. By technology, the recognition and surveillance segment accounted for a dominant market share in 2023. Based on end user, the public sector segment accounted for a dominant market share in 2023. Region wise, the North America region is the highest revenue contributor inโฆ
More Releases for Erythropoietin
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing theโฆ
Erythropoietin Drugs Market Size, Opportunities 2022-2030
The Erythropoietin Drugs Market. The report delves into current trends, growth drivers, competitive landscape, and future forecasts, providing invaluable insights for stakeholders looking to understand the dynamics of this rapidly evolving sector. The global erythropoietin drugs market is poised for substantial growth, and the insights provided in this report are crucial for navigating this promising landscape.
-------------------------------------------------------------------------------------------------------------------
REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2675
-------------------------------------------------------------------------------------------------------------------
Market Overview:
The global erythropoietin drugs market wasโฆ
Erythropoietin Drugs Market - Revitalizing Lives: Erythropoietin Drugs for Enhan โฆ
Newark, New Castle, USA: The "Erythropoietin Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Erythropoietin Drugs Market: https://www.growthplusreports.com/report/erythropoietin-drugs-market/8627
This latest report researches the industry structure, sales, revenue,โฆ
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Click to view theโฆ
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms ofโฆ
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports.
Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development ofโฆ
